Clinical Trial Update: Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of lentiviral-mediated gene therapy for Fanconi Anemia Type A has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fanconi Anemia

Snippet

Sponsor: Hospital Infantil Universitario Niño Jesús, Madrid, Spain | Conditions: Fanconi Anemia | Phase 1, Phase 2 | Status: COMPLETED